Business / Finance

RSS

Akorbi announces aggressive growth strategy in early 2012

Akorbi, one of the health insurance industry's largest suppliers of translation and interpretation services, announced an aggressive growth strategy in early 2012 that included the addition of multilingual and technology consulting staffing services.

21 Dec 2012

Echo Therapeutics prices underwritten public offering of 3,200,000 shares of common stock

Echo Therapeutics, Inc., a company developing its needle-free Symphony tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring system, today announced the pricing of a previously announced underwritten public offering of 3,200,000 shares of its common stock, offered at a price to the public of $0.95 per share.

20 Dec 2012

Coherent announces acquisition of Lumera Laser

Coherent, Inc. today announced that it had acquired privately held Lumera Laser GmbH (Kaiserslautern, Germany) for approximately $52 million in an all cash transaction.

20 Dec 2012

Ortho Kinematics closes more than $2 million in Series B financing

Ortho Kinematics‚ Inc. (OKI), a privately held healthcare diagnostics company focused on spine imaging informatics, announced today the close of more than $2 million in its Series B financing.

18 Dec 2012

Marketplace changes: Hospitals work on insurance arms; Walgreen eyes hospice business

A growing number of hospital systems are moving to start their own insurance plans, aiming to broaden their roles and prepare for the changes coming under the federal health-care overhaul. Piedmont Healthcare and WellStar Health System, both in the Atlanta area, are set to announce a jointly owned insurance arm, with the goal of marketing coverage to employers and Medicare recipients in 2014.

18 Dec 2012

Allakos closes $32M Series A financing to develop antibody-based therapeutics

Allakos Inc. announced today that it has completed a $32 million Series A preferred stock financing led by Novo Ventures with participation from Alta Partners, RiverVest Venture Partners and the Roche Venture Fund. Peter Moldt , PhD., Partner at Novo Ventures, Robert Alexander , PhD., Director at Alta Partners and John McKearn PhD., Managing Director at RiverVest Venture Partners, will join the Board of Directors.

17 Dec 2012

Naurex announces completion of $38M Series B financing

Naurex Inc., a clinical-stage company developing innovative treatments to address unmet needs in psychiatry and neurology, today announced the completion of a $38 million Series B financing led by new investor Baxter Ventures.

17 Dec 2012

Patheon acquires Banner Pharmacaps

Patheon Inc., a leading provider of contract development and manufacturing services to the global pharmaceutical industry, today announced that it has completed its acquisition of Banner Pharmacaps, a specialty pharmaceutical business dedicated to the research, development and manufacturing of unique gelatin-based dosage forms.

15 Dec 2012

Sister Kenny Rehabilitation Institute and Courage Center announce merger agreement

In a bold move meant to advance the care and services provided to the disability community, Courage Center and Allina Health announced today that their boards of directors have approved a proposed merger between the Sister Kenny Rehabilitation Institute and Courage Center.

15 Dec 2012

Zimmer authorizes cash dividend to stockholders for fourth quarter 2012

Zimmer Holdings, Inc., a global leader in musculoskeletal care, today announced that its Board of Directors has authorized a cash dividend to stockholders for the fourth quarter of 2012.

14 Dec 2012

CEL-SCI net loss decreases to $17.6 million for fiscal year 2012

CEL-SCI Corporation reported financial results today for the fiscal year ended September 30, 2012.

14 Dec 2012

Dr. Reddy's Laboratories launches public offer to acquire OctoPlus shares

Dr. Reddy's Laboratories Limited, together with its subsidiaries, launches the recommended public offer to acquire all the issued and outstanding shares of OctoPlus N.V., a service-based specialty pharmaceutical company, at an offer price of EUR 0.52 (cum dividend) per share.

14 Dec 2012

Amgen declares $0.47 per share dividend for first quarter 2013

Amgen announced that its Board of Directors today declared a $0.47 per share dividend for the first quarter of 2013.

14 Dec 2012

Champions Oncology operating revenues increase to $3.6M for six months ended October 31, 2012

Champions Oncology, Inc. (OTC: CSBR), engaged in the development of advanced technology solutions and services to personalize the development and use of oncology drugs, announced today its financial results for the fiscal quarter ended October 31, 2012.

13 Dec 2012

Max Reinhardt named worldwide President of Depuy Synthes Spine

The DePuy Synthes Companies of Johnson & Johnson announced today that Max Reinhardt has been named Worldwide President of DePuy Synthes Spine, a global leader in spinal care. Mr. Reinhardt has been with the company since 2002, most recently as Vice President of Worldwide Marketing.

13 Dec 2012

BioScrip to acquire HomeChoice

BioScrip, Inc. today announced that it has entered into a definitive agreement to acquire HomeChoice Partners, Inc., a leading provider of alternate-site infusion pharmacy services, for $70.0 million in cash.

13 Dec 2012

Concord Medical to acquire 19.98% ownership of MD Anderson Proton Therapy Center

Concord Medical Services Holdings Limited, a leading specialty hospital management solution provider and operator of the largest network of radiotherapy and diagnostic imaging centers in China, today announced the signing of a definitive agreement under which it will acquire 19.98% of indirect ownership of The University of Texas MD Anderson Cancer Center Proton Therapy Center (MD Anderson Proton Therapy Center), achieved through acquiring a minority interest in the general partner and facility manager.

13 Dec 2012

Unisense FertiliTech announces new partnership with William Demant Invest

Danish medtech company Unisense FertiliTech A/S announces a new partnership with Oticon Funds investment company William Demant Invest (WDI). WDI owns 32% of Unisense FertiliTech A/S after the purchase of new and existing shares in the company worth 24 million USD.

13 Dec 2012

Heartbeat Experts announces increased revenue and expanded clients in emerging markets

Heartbeat Experts, the global leader in stakeholder management solutions for the life sciences industry, announced today increased revenue and expanded clients across Brazil, Russia, China, India and Korea. Heartbeat Experts' reported combined revenue from these markets grew 50% in the third quarter of 2012.

13 Dec 2012

First Warning Systems announces Letter of Intent with UniCorp Biotech

First Warning Systems, Inc. announced a Letter of Intent with Budapest, Hungary, European Union based medical products marketing partner, UniCorp Biotech.

13 Dec 2012